Statin use and outcome in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated in the TROPIC trial
Authors
Lorente, DOria, GAD
Carles, J
Gillessen, Silke
Fizazi, K
Joshua, A
Eisenberger, M
Sartor, O
de Bono, JS
Affiliation
Medical Oncology, Hospital Universitario La Fe, Valencia, SpainIssue Date
2018
Metadata
Show full item recordCitation
Lorente D, De Velasco Oria GA, Carles J, Gillessen S, Fizazi K, Joshua A, et al. 809P Statin use and outcome in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated in the TROPIC trial. Annals of Oncology. 2018;29(suppl_8).Journal
Annals of OncologyDOI
10.1093/annonc/mdy284.018PubMed ID
No PMIDAdditional Links
https://dx.doi.org/10.1093/annonc/mdy284.018Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdy284.018